Send to:

Choose Destination
See comment in PubMed Commons below
Complement Ther Med. 2001 Mar;9(1):12-6.

Iscador Qu for chronic hepatitis C: an exploratory study.

Author information

  • 1Berg en Bosch Medical Centre, Bilthoven, the Netherlands.


Five patients with chronic hepatitis C were treated for one year with the herbal immunomodulatory agent Iscador (Weleda, Schwäbisch Gmünd Germany). Two patients showed 6-20 fold decreases in viral load and normalisation of liver inflammation. The treatment was well tolerated; no serious side effects were observed. The quality of life improved on average. Iscador may have potential as a non toxic therapy for chronic hepatitis C treatment.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk